# EDGAR Filing Document

**Accession Number:** 0001596812
**File Stem:** 0001213900-26-019019
**Filing Date:** 2026-2
**Character Count:** 5804
**Document Hash:** 717a6862df8c20665140435758357cf5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-019019.hdr.sgml**: 20260223

**ACCESSION NUMBER**: 0001213900-26-019019

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260223

**FILED AS OF DATE**: 20260223

**DATE AS OF CHANGE**: 20260223

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Enlivex Ltd.
- **CENTRAL INDEX KEY:** 0001596812
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36578
- **FILM NUMBER:** 26662128

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 37 DEREH MENACHEM BEGIN ST.
- **STREET 2:** 15TH FLOOR
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3
- **BUSINESS PHONE:** 972 (0) 3 7326616

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 37 DEREH MENACHEM BEGIN ST.
- **STREET 2:** 15TH FLOOR
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Enlivex Therapeutics Ltd.
- **DATE OF NAME CHANGE:** 20190326

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bioblast Pharma Ltd.
- **DATE OF NAME CHANGE:** 20160919

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BIO BLAST PHARMA LTD.
- **DATE OF NAME CHANGE:** 20140113

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of: February 2026

Commission file number: 001-36578

<u>ENLIVEX LTD.</u>

(Translation of registrant's name into English)

<u>14 Einstein Street, Nes Ziona, Israel 7403618</u>

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

**Change of Company's Name**

On February 3, 2026, Enlivex Therapeutics Ltd., a company organized under the laws of the State of Israel (the "<u>Company</u>"), held an Extraordinary General Meeting of Shareholders of the Company (the "<u>Meeting</u>"). At the Meeting, the shareholders voted on and approved (among other things) a proposal to change the Company's name to "Enlivex Ltd." or to such other name containing the word "Enlivex" as may be determined by the Company's management and approved by the Israeli Registrar of Companies. On February 10, 2026, the Registrar of Companies in Israel issued a Certificate of Change of Name effecting the Company's name change to Enlivex Ltd. (the "<u>Certificate</u>"). A complete copy of the Certificate is filed as Exhibit 99.1 to this Report on Form 6-K and incorporated herein by reference.

The information contained in this Report on Form 6-K, including Exhibit 99.1, is hereby incorporated by reference into the Company's registration statements on Forms S-8, F-3 and F-3MEF (File No. [333-256799](http://www.sec.gov/Archives/edgar/data/1596812/000121390021030986/ea141958-s8_enlivextherap.htm), File No. [333-232413](http://www.sec.gov/Archives/edgar/data/1596812/000121390019011719/ff32019_enlivextherapeutics.htm), File No. [333-232009](http://www.sec.gov/Archives/edgar/data/1596812/000121390019010285/ff32019_enlivextherapeutics.htm), File No. [333-252926](http://www.sec.gov/Archives/edgar/data/1596812/000121390021007889/ea135073-f3mef_enlivextherap.htm), File No. [333-286956](http://www.sec.gov/Archives/edgar/data/1596812/000121390025039303/ea0240501-f3_enlivex.htm) and File No. [333-292417](http://www.sec.gov/Archives/edgar/data/1596812/000121390025125374/ea0270663-f3_enlivex.htm)), filed with the U.S. Securities and Exchange Commission.

---

| | |
|:---|:---|
| **Exhibit No.** |  |
| 99.1 | [Certificate of Change of Name, filed with the Registrar of Companies in Israel on February 10, 2026.](ea027790701ex99-1_enlivex.htm) |

---

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| Enlivex Ltd. | Enlivex Ltd. |
| (Registrant) | (Registrant) |
| By: | /s/ Oren Hershkovitz |
| Name: <br> Title: | Oren Hershkovitz<br> Chief Executive Officer |

---

Date: February 23, 2026

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

CERTIFICATE OF CHANGE OF NAME This is to certify that the company: Company Number: 514716489 Changed its name in Israel according to Companies Laws in the State of Israel, and beginning of 10TH FEBRUARY 2026 it will be called: Shuli Avni-Shoham, Adv. Registrar of Companies Head of the Israeli Corporations Authority PRODUCED ON 10TH FEBRUARY 2026 AT 17:00 To obtain a company information summary, scan the barcode or click here Produced on 10 th February 2026 At 17:00 ୭ " ୬ஂ஁୼ ஁୩୰ ୪ " ୳ 10 / 02 / 2026 ୩ୱ୭୵ ୬୭୼୿୬ 17:00 ୩஁୺୬ To obtain a company information summary, scan the barcode or click here , ஂ୶୾ୱஂ ୶ୱ୫୺ ୺୴ ୬୯୩஀୬ - ୴୬୼୿ஂ ୸୹୯ ୯୩஀୬ ୱ஁ ୴୹஀୭୿ ୨ஂ ୬୩஀୿୭୫ ୨୭ ୴୴୯୭୽ ୳୨୷ ஁୵ ஁ୱ୸୭ୱ ஂ୺୭୫ஂ CERTIFICATE OF CHANGE OF NAME : ୬୯୩஀୬ ୳ୱ ୴ஂ୺୭୫୬ ୭୮୨ஂ This is to certify that the company: ୶ " ୩୺ ஂ஀୼ୱ୭୰ୱ୿୹ ୨୸୴ୱୱ୩୿୹ ENLIVEX THERAPEUTICS LTD Company Number: 514716489 : ୯୩஀୬ ୶୹୼஀ Changed its name in Israel according to Companies Laws in the State of Israel, and beginning of 10 th February 2026 it will be called: ୩ୱ஁஀୨୴ ஁୶୬ ୨ஂ ஁ୱ୸ஂ୬ , ୱ஁஀୨୴ ୩୶୫ୱ୸ஂ ୬୯୩஀୭ஂ ୫ୱ୸ୱ ୴୼ୱ ୭ " ୬ஂ஁୼ ஁୩୰ ୪ " ୳ , 10 / 02 / 2026 ୶ୱ୭୵ ୭୬୯୴ : ୩஁୵ ஂୱ୿஀୨ ୶ " ୩୺ ୨୸୴ୱୱ୩୿୹ ENLIVEX LTD Shuli Avni - Shoham, Adv. Registrar of Companies Head of the Israeli Corporations Authority ୫ " ୺୭ , ஁୭୬୵ - ୨୩୸ୱ ஁୭୴ୱ ୬୯୩஀୭ஂ ஀஁୶ஂ ୬ஂ୨୪ୱ୫ୱ୵ ஀஁୭ஂ ஀୨஁